Curis Inc. [NASDAQ: CRIS] price surged by 14.33 percent to reach at $1.31. The company report on January 14, 2021 that Curis to Present at B. Riley Securities Virtual Oncology Investor Conference.
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced that James Dentzer, President and Chief Executive Officer of Curis, will participate in a fireside chat at the B. Riley Securities Virtual Oncology Investor Conference on Thursday, January 21, 2021 at 11:00 am ET.
A live webcast of the presentation will be available under “Events & Presentations” in the Investors section of the Company’s website at www.curis.com. A replay of the webcast will be available on the Curis website for 90 days following the event.
A sum of 4524515 shares traded at recent session while its average daily volume was at 9.39M shares. Curis Inc. shares reached a high of $11.90 and dropped to a low of $10.15 until finishing in the latest session at $10.45.
The one-year CRIS stock forecast points to a potential upside of 33.65. The average equity rating for CRIS stock is currently 2.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Curis Inc. [CRIS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRIS shares is $15.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRIS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Laidlaw have made an estimate for Curis Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 29, 2020. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on July 17, 2020, representing the official price target for Curis Inc. stock. Previously, the target price had yet another raise to $7, while Guggenheim analysts kept a Buy rating on CRIS stock.
The Average True Range (ATR) for Curis Inc. is set at 1.16, with the Price to Sales ratio for CRIS stock in the period of the last 12 months amounting to 67.77.
CRIS Stock Performance Analysis:
Curis Inc. [CRIS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.65. With this latest performance, CRIS shares gained by 37.50% in over the last four-week period, additionally plugging by 749.59% over the last 6 months – not to mention a rise of 545.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRIS stock in for the last two-week period is set at 57.93, with the RSI for the last a single of trading hit 54.61, and the three-weeks RSI is set at 60.92 for Curis Inc. [CRIS]. The present Moving Average for the last 50 days of trading for this stock 6.99, while it was recorded at 9.77 for the last single week of trading, and 2.58 for the last 200 days.
Insight into Curis Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Curis Inc. [CRIS] shares currently have an operating margin of -243.46 and a Gross Margin at +93.72. Curis Inc.’s Net Margin is presently recorded at -321.28.
Return on Total Capital for CRIS is now -81.57, given the latest momentum, and Return on Invested Capital for the company is -122.05. Additionally, CRIS Total Debt to Total Capital is recorded at 218.03, with Total Debt to Total Assets ending up at 178.23.
Reflecting on the efficiency of the workforce at the company, Curis Inc. [CRIS] managed to generate an average of -$1,147,893 per employee. Receivables Turnover for the company is 3.28 with a Total Asset Turnover recorded at a value of 0.28.Curis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.10 and a Current Ratio set at 3.10.
CRIS Stock EPS
With the latest financial reports released by the company, Curis Inc. posted -0.22/share EPS, while the average EPS was predicted by analysts to be reported at -0.3/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 26.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRIS.
Curis Inc. [CRIS] Insider Position Details
There are presently around $230 million, or 25.60% of CRIS stock, in the hands of institutional investors. The top three institutional holders of CRIS stocks are: SIO CAPITAL MANAGEMENT, LLC with ownership of 4,950,051, which is approximately 15.116% of the company’s market cap and around 0.10% of the total institutional ownership; BVF INC/IL, holding 3,650,000 shares of the stock with an approximate value of $38.14 million in CRIS stocks shares; and EMERALD ADVISERS, LLC, currently with $16.41 million in CRIS stock with ownership of nearly New of the company’s market capitalization.
Positions in Curis Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 33 institutional holders increased their position in Curis Inc. [NASDAQ:CRIS] by around 4,652,696 shares. Additionally, 16 investors decreased positions by around 2,484,667 shares, while 13 investors held positions by with 14,883,171 shares. The mentioned changes placed institutional holdings at 22,020,534 shares, according to the latest SEC report filing. CRIS stock had 16 new institutional investments in for a total of 3,103,132 shares, while 7 institutional investors sold positions of 599,524 shares during the same period.